Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Signs Lease for New European Headquarters in Cambridge

NEW YORK (GenomeWeb) – BioMed Realty Trust today announced that Illumina has signed a 20-year lease for a new research building and European headquarters in Cambridge, England.

"This new state-of-the-art European Headquarters will provide enhanced collaboration opportunities for our growing employee base, which is so foundational to Illumina's innovation and success," Illumina CFO Marc Stapley said in a statement.

The building will be housed in Granta Park, a scientific research center eight miles away from Cambridge University that is owned, managed, and operated by BioMed Realty Trust. The real estate firm said in a statement that it acquired the land for the Illumina building from the Welding Institute under a long-term ground lease.

Illumina will have the ability to expand the 155,000-square-foot building by 70,000 square feet, BioMed Realty Trust said.  

According to a document filed by Illumina with the US Securities and Exchange Commission, the aggregate rent during the initial term of the lease is expected to be approximately £94 million ($148.1 million)

In January, Illumina signed a 15-year lease with BioMed Realty Trust for a 360,000-square-foot campus in Foster City, California.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.